Literature DB >> 16181129

Pharmacogenomics: integration into drug discovery and development.

Keith Johnson1, John Thompson, Aidan Power.   

Abstract

To deliver on the promise of personalized medicine requires the integration of pharmacogenomics into the discovery and development of medicines. Over the last few years the pharmaceutical industry has been building considerable resources to achieve that. However, this requires new skill sets, capabilities and infrastructures which have not been a traditional part of the industry's efforts. In this article we describe how the integration of genetics and pharmacogenomics data has begun to deliver success and illustrate the challenges that the new science and technologies bring and how these challenges can be addressed in order to deliver on the promise.

Mesh:

Year:  2005        PMID: 16181129     DOI: 10.2174/156802605774297047

Source DB:  PubMed          Journal:  Curr Top Med Chem        ISSN: 1568-0266            Impact factor:   3.295


  1 in total

Review 1.  Pharmacogenomics in early-phase clinical development.

Authors:  Tal Burt; Savita Dhillon
Journal:  Pharmacogenomics       Date:  2013-07       Impact factor: 2.533

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.